Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes

NCT00359879 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

377

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: exenatide
DRUG: exenatide

Sponsor

AstraZeneca

Collaborators

[object Object]